Vitamin B12 deficiency

Vitamin B12 deficiency
Other names	Hypocobalaminemia, cobalamin deficiency
Image of the cervical spinal cord in vitamin B12 deficiency showing subacute combined degeneration. (A) The midsagittal T2 weighted image shows linear hyperintensity in the posterior portion of the cervical tract of the spinal cord (black arrows). (B) Axial T2 weighted images reveal the selective involvement of the posterior columns.
Specialty	Neurology, hematology
Symptoms	Decreased ability to think, feeling tired, depression, irritability, abnormal sensations, changes in reflexes [1]
Complications	Megaloblastic anemia, irreversible damage to the brain and nervous system [2]
Causes	Poor absorption, decreased intake, increased requirements [1]
Diagnostic method	Blood levels below 148–185 pmol/L (200–250 pg/mL) in adults [2]
Prevention	Supplementation in those at high risk [2]
Treatment	Supplementation by mouth or injection [3]
Frequency	6% (< 60 years old), 20% (> 60 years old) [4]

Vitamin B₁₂ deficiency, also known as cobalamin deficiency, is the medical condition in which the blood and tissue have a lower than normal level of vitamin B₁₂. ^[5] Symptoms can vary from none to severe. ^[1] Mild deficiency may have few or absent symptoms. ^[1] In moderate deficiency, feeling tired, headaches, soreness of the tongue, mouth ulcers, breathlessness, feeling faint, rapid heartbeat, low blood pressure, pallor, hair loss, decreased ability to think and severe joint pain and the beginning of neurological symptoms, including abnormal sensations such as pins and needles, numbness and tinnitus may occur. ^[1] Severe deficiency may include symptoms of reduced heart function as well as more severe neurological symptoms, including changes in reflexes, poor muscle function, memory problems, blurred vision, irritability, ataxia, decreased smell and taste, decreased level of consciousness, depression, anxiety, guilt and psychosis. ^[1] If left untreated, some of these changes can become permanent. ^{[1] [6]} Temporary infertility, reversible with treatment, may occur. ^{[1] [7]} A late finding type of anemia known as megaloblastic anemia is often but not always present. ^[2] In exclusively breastfed infants of vegan mothers, undetected and untreated deficiency can lead to poor growth, poor development, and difficulties with movement. ^[2]

Causes are usually related to conditions that give rise to malabsorption of vitamin B₁₂ particularly autoimmune gastritis in pernicious anemia. ^[8] Other conditions giving rise to malabsorption include surgical removal of the stomach, chronic inflammation of the pancreas, intestinal parasites, certain medications such as long-term use of proton pump inhibitors, H2-receptor blockers, and metformin, and some genetic disorders. ^{[1] [9]} Deficiency can also be caused by inadequate dietary intake such as with the diets of vegetarians, and vegans, and in the malnourished. ^[1] Deficiency may be caused by increased needs of the body for example in those with HIV/AIDS, and shortened red blood cell lifespan. ^[1] Diagnosis is typically based on blood levels of vitamin B₁₂ below 148–185 pmol/L (200 to 250 pg/mL) in adults. ^[2] Diagnosis is not always straightforward as serum levels can be falsely high or normal. ^[10] Elevated methylmalonic acid levels may also indicate a deficiency. ^[2] Individuals with low or marginal values of vitamin B₁₂ in the range of 148–221 pmol/L (200–300 pg/mL) may not have classic neurological or hematological signs or symptoms. ^[2]

Treatment is by vitamin B₁₂ supplementation, either by mouth or by injection. ^[3] Initially in high daily doses, followed by less frequent lower doses, as the condition improves. ^[3] If a reversible cause is found, that cause should be corrected if possible. ^[11] If no reversible cause is found, or when found it cannot be eliminated, lifelong vitamin B₁₂ administration is usually recommended. ^[12] A nasal spray is also available. ^[2] Vitamin B₁₂ deficiency is preventable with supplements, which are recommended for pregnant vegetarians and vegans, and not harmful in others. ^[2] Risk of toxicity due to vitamin B₁₂ is low. ^[2]

Vitamin B₁₂ deficiency in the US and the UK is estimated to occur in about 6 percent of those under the age of 60, and 20 percent of those over the age of 60. ^[4] In Latin America, about 40 percent are estimated to be affected, and this may be as high as 80 percent in parts of Africa and Asia. ^[1] Marginal deficiency is much more common and may occur in up to 40% of Western populations. ^[2]

Signs, symptoms and complications

Possible oral manifestation of B₁₂ deficiency: erythema and depapillation of the tongue in a patient. From Kim et al., 2016.

Vitamin B₁₂ deficiency appears slowly and worsens over time, and can often be confused with other conditions. ^[14] It may often go unrecognized, as the body becomes used to feeling unwell.

Vitamin B₁₂ deficiency can lead to anemia, neurologic, and digestive dysfunctions. ^{[15] [16] [17]} A mild deficiency may not cause any discernible symptoms, but at levels moderately lower than normal, a range of symptoms such as feeling tired, weak, lightheadedness, headaches, dizziness, rapid breathing, rapid heartbeat, cold hands and feet, low-grade fevers, tremor, cold intolerance, easy bruising and bleeding, pale skin, low blood pressure, sore tongue, upset stomach, loss of appetite, weight loss, constipation, diarrhea, severe joint pain, feeling abnormal sensations including numbness or tingling (pins and needles) to the fingers and toes, and tinnitus, may be experienced. ^{[18] [19] [20] [21]} A wide range of associated symptoms may include angular cheilitis, mouth ulcers, bleeding gums, hair loss and thinning, premature greying, a look of exhaustion and dark circles around the eyes, as well as brittle nails. ^[6]

Severe vitamin B₁₂ deficiency can damage nerve cells. ^[7] If this happens, vitamin B₁₂ deficiency may result in sense loss, loss of sensation in the feet, difficulty walking, poor balance, blurred vision, changes in reflexes, muscle weakness, decreased smell and taste, decreased level of consciousness, mood changes, memory loss, depression, irritability, anxiety, clumsiness, disorientation, psychosis and, in severe cases, dementia. ^{[22] [23]} Tissue deficiencies may negatively affect nerve cells, bone marrow, and the skin. ^[5]

A further complication of severe deficiency is the neurological complex known as subacute combined degeneration of spinal cord. ^{[24] [25]} also myelosis funicularis, ^[26] or funicular myelosis. ^[25] This complex consists of the following symptoms:

1. Impaired perception of deep touch, pressure and vibration, loss of sense of touch, very annoying and persistent paresthesias
2. Ataxia of dorsal column type
3. Decrease or loss of deep muscle-tendon reflexes
4. Pathological reflexes – Babinski, Rossolimo and others, also severe paresis.

The presence of peripheral sensory-motor symptoms or subacute combined degeneration of spinal cord strongly suggests the presence of a B₁₂ deficiency instead of folate deficiency. Methylmalonic acid, if not properly handled by B₁₂, remains in the myelin sheath, causing fragility. Dementia and depression have been associated with this deficiency as well, possibly from the under-production of methionine because of the inability to convert homocysteine into this product. Methionine is a necessary cofactor in the production of several neurotransmitters. Each of those symptoms can occur either alone or with others. Vitamin B₁₂ is essential for the development of the brain. Its deficiency can cause neurodevelopmental problems which can be partly reversible with early treatment. ^[27] Only a small subset of dementia cases have been found to be reversible with vitamin B₁₂ therapy. ^[28] Tinnitus may be associated with vitamin B₁₂ deficiency. ^[29]

Vitamin B₁₂ deficiency may accompany certain eating disorders or restrictive diets. ^[30]

Pernicious anemia

Pernicious anemia is a disease caused by an autoimmune response that produces antibodies that attack the parietal cells in the stomach lining, preventing them from creating intrinsic factor needed for the absorption of vitamin B₁₂. ^{[1] [2]} It is the main and most common cause of vitamin B₁₂ deficiency anemia in developed countries, ^[2] and is characterized by a triad of symptoms:

1. Anemia with bone marrow promegaloblastosis (megaloblastic anemia). This is due to the inhibition of DNA synthesis (specifically purines and thymidine).
2. Gastrointestinal symptoms: alteration in bowel motility, such as mild diarrhea or constipation, and loss of bladder or bowel control. ^[31] These may be due to defective DNA synthesis inhibiting replication in a site with a high turnover of cells. This may also result from the autoimmune attack on parietal cells of the stomach. There is an association with "watermelon stomach" (GAVE) and pernicious anemia. ^{[32] [33]}
3. Neurological symptoms: Sensory or motor deficiencies (absent reflexes, diminished vibration or soft touch sensation), subacute combined degeneration of spinal cord, or seizures. ^{[34] [35]} Deficiency symptoms in children include developmental delay, regression, irritability, involuntary movements, and hypotonia. ^[36]

In babies, neurological symptoms can occur from malnutrition or pernicious anemia in the mother. These include poor growth, apathy, having no desire for food, and developmental regression. While most symptoms resolve with supplementation, some developmental and cognitive problems may persist. ^[37]

Metabolic risk in offspring

Vitamin B₁₂ is a critical micronutrient essential for supporting the increasing metabolic demands of the foetus during pregnancy. ^[38] B₁₂ deficiency in pregnant women is increasingly common ^[39] and has been shown to be associated with major maternal health implications, including increased obesity, ^[39] higher body mass index (BMI), ^[40] insulin resistance, ^[38] gestational diabetes, and type 2 diabetes (T2D) in later life. ^[41] A study in a pregnant white non-diabetic population in England, found that for every 1% increase in BMI, there was 0.6% decrease in circulating B₁₂. ^[38] Furthermore, an animal study in ewes demonstrated that a B₁₂, folate and methionine restricted diet around conception, resulted in offspring with higher adiposity, blood pressure and insulin resistance which could be accounted for by altered DNA methylation patterns. ^[42]

Both vitamin B₁₂ and folate are involved in the one-carbon metabolism cycle. In this cycle, vitamin B₁₂ is a necessary cofactor for methionine synthase, an enzyme involved in the methylation of homocysteine to methionine. ^[43] DNA methylation is involved in the functioning of genes and is an essential epigenetic control mechanism in mammals. This methylation is dependent on methyl donors such as vitamin B₁₂ from the diet. ^[44] Vitamin B₁₂ deficiency has the potential to influence methylation patterns in DNA, besides other epigenetic modulators such as micro (RNAs), leading to the altered expression of genes. ^{[45] [46]} Consequently, an altered gene expression can possibly mediate impaired foetal growth and the programming of non-communicable diseases. ^{[47] [45]}

Vitamin B₁₂ and folate status during pregnancy is associated with the increasing risk of low birth weight, ^{[39] [48]} preterm birth, ^[48] insulin resistance and obesity ^{[38] [40]} in the offspring. In addition it has been associated with adverse foetal and neonatal outcomes including neural tube defects (NTDs) ^{[49] [50] [51] [52]} and delayed myelination or demyelination. ^{[37] [53]} The mother's B₁₂ status can be important in determining the later health of the child, as shown in the Pune maternal Nutrition Study, conducted in India. In this study, children born to mothers with high folate concentrations and low vitamin B₁₂ concentrations were found to have higher adiposity and insulin resistance at age 6. In the same study, over 60% of pregnant women were deficient in vitamin B₁₂, which was considered to increase the risk of gestational and later diabetes in the mothers. ^[40] Increased longitudinal cohort studies or randomised controlled trials are required to understand the mechanisms between vitamin B₁₂ and metabolic outcomes, and to potentially offer interventions to improve maternal and offspring health. ^[54]

Cardiometabolic disease outcomes

Multiple studies have explored the association between vitamin B₁₂ and metabolic disease outcomes, such as obesity, insulin resistance and the development of cardiovascular disease. ^{[55] [56] [57]} A long-term study where vitamin B₁₂ was supplemented across a period of 10 years, led to lower levels of weight gain in overweight or obese individuals (p < 0.05). ^[58]

There are several mechanisms which may explain the relationship between obesity and decreased vitamin B₁₂ status. Vitamin B₁₂ is a major dietary methyl donor, involved in the one-carbon cycle of metabolism and a recent genome-wide association (GWA) analysis showed that increased DNA methylation is associated with increased BMI in adults, ^[59] consequently a deficiency of vitamin B₁₂ may disrupt DNA methylation and increase non-communicable disease risk. Vitamin B₁₂ is also a co-enzyme which converts methylmalonyl-CoA to succinyl-CoA in the one carbon cycle. If this reaction cannot occur, methylmalonyl-CoA levels elevate, inhibiting the rate-limiting enzyme of fatty acid oxidation (CPT1 – carnitine palmitoyl transferase), leading to lipogenesis and insulin resistance. ^[60] Further to this, reduced vitamin B₁₂ concentrations in the obese population is thought to result from repetitive short-term restrictive diets and increased vitamin B₁₂ requirements secondary to increased growth and body surface area. ^{[55] [61]} It has also been hypothesised that low vitamin B₁₂ concentrations in obese individuals are a result of wrong feeding habits, where individuals consume a diet low in micronutrient density. ^[62] Finally, vitamin B₁₂ is involved in the production of red blood cells, and vitamin B₁₂ deficiency can result in anemia, which causes fatigue and the lack of motivation to exercise. ^[58]

The investigation into the relationship between cardiovascular disease (CVD) and vitamin B₁₂ has been limited, and there is still controversy as to whether primary intervention with vitamin B₁₂ will lower cardiovascular disease. ^[63] Deficiency of vitamin B₁₂ can impair the remethylation of homocysteine in the methionine cycle, and result in raised homocysteine levels. ^[64] There is much evidence linking elevated homocysteine concentrations with an increased risk of cardiovascular disease, ^[65] and homocysteine lowering treatments have led to improvements in cardiovascular reactivity and coagulation factors. ^[66] In adults with metabolic syndrome, individuals with low levels of vitamin B₁₂ had higher levels of homocysteine compared to healthy subjects. ^[67] It is thus possible that vitamin B₁₂ deficiency enhances the risk of developing cardiovascular disease in individuals who are obese. ^[55] Alternatively, low levels of vitamin B₁₂ may increase the levels of proinflammatory proteins which may induce ischaemic stroke. ^{[68] [69]}

It is important to screen vitamin B₁₂ deficiency in obese individuals, due to its importance in energy metabolism, and relationship with homocysteine and its potential to modulate weight gain. ^[62] More studies are needed to test for the causality of vitamin B₁₂ and obesity using genetic markers. ^[70] A few studies have also reported no deficiency of vitamin B₁₂ in obese individuals. ^{[71] [72] [73] [74]} Finally, a recent literature review conducted over 19 studies, found no evidence of an inverse association between BMI and circulating vitamin B₁₂. ^[70]

Previous clinical and population-based studies have indicated that vitamin B₁₂ deficiency is prevalent amongst adults with type 2 diabetes. ^{[75] [76]} Kaya et al., conducted a study in women with polycystic ovary syndrome, and found that obese women with insulin resistance had lower vitamin B₁₂ concentrations compared to those without insulin resistance. ^[77] Similarly, in a study conducted in European adolescents, there was an association between high adiposity and higher insulin sensitivity with vitamin B₁₂ concentrations. Individuals with a higher fat mass index and higher insulin sensitivity (high Homeostatic Model Assessment [HOMA] index) had lower plasma vitamin B₁₂ concentrations. ^[78] Furthermore, a recent study conducted in India reported that mean levels of vitamin B₁₂ decreased with increasing levels of glucose tolerance e.g. individuals with type 2 diabetes had the lowest values of vitamin B₁₂, followed by individuals with pre-diabetes and normal glucose tolerance, respectively. ^[79] However, B₁₂ levels of middle aged-women with and without metabolic syndrome ^[80] showed no difference in vitamin B₁₂ levels between those with insulin resistance (IR) and those without. It is believed that malabsorption of vitamin B₁₂ in diabetic patients, is due to individuals taking metformin therapy (an insulin sensitizer used for treating type 2 diabetes). ^[81] Furthermore, obese individuals with type 2 diabetes are likely to develop gastroesophageal reflux disease, ^[82] and take proton pump inhibitors, which further increased the risk of vitamin B₁₂ deficiency. ^[70]

A literature review conducted in 2011 over seven studies, found that there was limited evidence to show that low vitamin B₁₂ status increased the risk of cardiovascular disease and diabetes. ^[83] However, the review did not identify any associations between vitamin B₁₂ and cardiovascular disease in the remaining four studies. ^[83] Currently, no data supports vitamin B₁₂ supplementation on reducing the risk of cardiovascular disease. In a dose-response meta-analysis of five prospective cohort studies, it was reported that the risk of coronary heart disease (CHD) did not change substantially with increasing dietary vitamin B₁₂ intake. ^[84] Of these five studies, three of the studies stated a non-significant positive association and two of the studies demonstrated an inverse association between vitamin B₁₂ supplementation and coronary heart disease (only one of the studies was significant). ^[84]

Anemia

Vitamin B₁₂ deficiency is one of the main causes of anemia. ^[16] In countries where B₁₂ deficiency is common, it is generally assumed that there is a greater risk of developing anemia. However, the overall contribution of vitamin B₁₂ deficiency to the global incidence of anemia may not be significant, except in elderly individuals, vegetarians, cases of malabsorption and some genetic disorders. ^[85] Anemia is defined as a condition in which there are not enough red blood cells, as the tissues and organs of the body do not get enough oxygen. Megaloblastic anemia caused by vitamin B₁₂ deficiency is characterized by red blood cells that are larger than normal and are unable to deliver oxygen to the body's organs. ^{[7] [8]} The clinical case indicates an altered synthesis of DNA, in which vitamin B₁₂ is essential for the production and maturation of red blood cells in the bone marrow. ^[8] Adult patients often report to medical attention symptoms related to anemia, such as feeling tired and weak, breathlessness, exercise intolerance, feeling faint, headaches, paleness, dry lips and a disturbance of taste. ^[8]

Pernicious anemia is the most common cause of vitamin B₁₂ deficiency anemia in adults, which results from malabsorption of vitamin B₁₂ due to a lack or loss of intrinsic factor. ^{[2] [8]} There are relatively few studies which have assessed the impact of haematological measures in response to B₁₂ supplementation. One study in 184 premature infants, reported that individuals given monthly vitamin B₁₂ injections (100 μg) or taking supplements of vitamin B₁₂ and folic acid (100 μg/day), had higher haemoglobin concentrations after 10–12 weeks, compared to those only taking folic acid or those taking no vitamin B₁₂ injections. ^[86] In deficient Mexican adult women and pre-schoolers, it was found that vitamin B₁₂ supplementation did not affect any haematologic parameters. ^{[87] [88]}

Aging

In the elderly, vitamin B₁₂ deficiency has been associated with the development of macular degeneration, and the risk of frailty. ^[89] Macular degeneration is the leading cause of severe, irreversible vision loss in older adults. ^{[90] [91]} Several risk factors have been linked to macular degeneration, including family history, genetics, hypercholesterolemia, hypertension, sunlight exposure and lifestyle (smoking and diet). ^{[92] [93] [94]} It has been shown that daily supplementation of vitamin B₁₂, B₆ and folate over a period of seven years can reduce the risk of age-related macular degeneration by 34% in women with increased risk of vascular disease (n=5,204). ^[95] However, another study failed to find an association between age-related macular degeneration and vitamin B₁₂ status in a sample of 3,828 individuals representative of the non-institutionalized US population. ^[96]

Frailty is a geriatric condition which is characterized by diminished endurance, strength, and reduced physiological function that increases an individual's risk of mortality and impairs an individual from fulfilling an independent lifestyle. ^[97] Frailty is associated with an increased vulnerability to fractures, falls from heights, reduced cognitive function and more frequent hospitalisation. ^[98] The worldwide prevalence of frailty within the geriatric population is 13.9%, ^[99] therefore there is an urgent need to eliminate any risk factors associated with frailty. Poor vitamin B status has been shown to be associated with an increased risk of frailty. Two cross sectional studies have reported that deficiencies of vitamin B₁₂ were associated with the length of hospital stay, as observed by serum vitamin B₁₂ concentrations and methylmalonic acid (MMA) concentrations. ^[100] Furthermore, another study of elderly women, found that certain genetic variants associated with vitamin B₁₂ status (tanscobalamin II) may contribute to reduced energy metabolism, consequently contributing to frailty. ^[101] Given that there are limited studies assessing the relationship between vitamin B₁₂ and frailty status, more longitudinal studies are needed to clarify the relationship.

Neurological decline

Severe vitamin B₁₂ deficiency is associated with subacute combined degeneration of the spinal cord, which involves demyelination of the posterior and lateral columns of the spinal cord. ^[102] Symptoms include memory and cognitive impairment, sensory loss, motor disturbances, personality changes, disorientation, irritability, dementia, loss of posterior column functions and disturbances in proprioception. ^{[103] [104] [105]} In advanced stages of vitamin B₁₂ deficiency, cases of psychosis, paranoia and severe depression have been observed, which may lead to permanent disability if left untreated. ^{[102] [103] [104]} Studies have shown the rapid reversal of the neurological symptoms of vitamin B₁₂ deficiency, after treatment with high-dose of vitamin B₁₂ supplementation; suggesting the importance of prompt treatment in reversing neurological manifestations. ^[106]

Cognitive decline

Elderly individuals are currently assessed on vitamin B₁₂ status during the screening process for dementia. Studies investigating the association between vitamin B₁₂ concentrations and cognitive status have produced inconclusive results. ^{[89] [107] [108]} It has been shown that elevated MMA concentrations are associated with decreased cognitive decline and Alzheimer's disease. ^[109] In addition, low vitamin B₁₂ and folate intakes have shown associations with hyperhomocysteinemia, which is associated with cerebrovascular disease, cognitive decline and an increased risk of dementia in prospective studies. ^[110]

There are limited intervention studies which have investigated the effect of supplementation of vitamin B₁₂ and cognitive function. A Cochrane review, analysing two studies, found no effect of vitamin B₁₂ supplementation on the cognitive scores of older adults. ^{[111] [ needs update ]} A recent longitudinal study in elderly individuals, found that individuals had a higher risk of brain volume loss over a 5-year period, if they had lower vitamin B₁₂ and holoTC levels and higher plasma tHcy and MMA levels. ^[112] More intervention studies are needed to determine the modifiable effects of vitamin B₁₂ supplementation on cognition. ^[89]

Osteoporosis

There has been growing interest on the effect of low serum vitamin B₁₂ concentrations on bone health. ^{[113] [114]} Studies have found a connection between elevated plasma tHcy and an increased risk of bone fractures, but is unknown whether this is related to the increased levels of tHcy or to vitamin B₁₂ levels (which are involved in homocysteine metabolism). ^[115] Results from the third NHANES conducted in the United States, found that individuals had significantly lower bone mass density (BMD) and higher osteoporosis rates with each higher quartile of serum MMA (n= 737 men and 813 women). ^[116] Given that poor bone mineralization has been found in individuals with pernicious anemia, ^[117] and that the content of vitamin B₁₂ within bone cells in culture has shown to affect the functioning of bone forming cells (osteoblasts); ^[118] it is possible that vitamin B₁₂ deficiency is causally related to poor bone health.

Randomized intervention trials investigating the association of vitamin B₁₂ supplementation and bone health have yielded mixed results. One study conducted on osteoporotic risk patients with hyperhomocysteinemia found positive effects between supplementation of B vitamins on BMD. ^[119] However, no improvement in BMD was observed in a group of healthy older people. ^[120] Further, controlled trials are needed to confirm the impact and mechanisms vitamin B₁₂ deficiency has on bone mineralization. ^[121]

Causes

Vitamin B₁₂ deficiency can be caused by impaired absorption, inadequate dietary intake, or increased requirements. ^[1] Impaired absorption explains most cases of vitamin B₁₂ deficiency, but it can also result from other factors. ^[2]

Impaired absorption

• Lack of intrinsic factor: intrinsic factor is a protein produced by parietal cells in the stomach, and needed in the ileum for the absorption of vitamin B₁₂. Lack of intrinsic factor is most commonly due to an autoimmune attack on the cells that create it in the stomach, and this condition takes the name "pernicious anemia". ^{[122] [123] [124]} PA may be considered as an end stage of autoimmune atrophic gastritis, a disease characterised by stomach atrophy and the presence of antibodies to parietal cells and intrinsic factor. ^[125] It can also occur following the surgical removal of all or part of the stomach or small intestine; from an inherited disorder or illnesses that damage the stomach lining. Gastric surgeries that involve the removal of all or part of the stomach, such as Roux-en-Y gastric bypass or surgical removal of the small bowel results in short bowel syndrome. ^[126]
• Digestive conditions: conditions that can give rise to impaired absorption of vitamin B₁₂ may include achlorhydria, Crohn's disease, coeliac disease, chronic pancreatitis, and some intestinal parasites. ^[127] Forms of achlorhydria (including that artificially induced by drugs such as proton pump inhibitors and histamine 2 receptor antagonists) can cause B₁₂ malabsorption from foods, since acid is needed to split B₁₂ from food proteins and salivary binding proteins. ^[128] This process is thought to be the most common cause of low B₁₂ in the elderly, who often have some degree of achlorhydria without being formally low in intrinsic factor. ^[127] This process does not affect absorption of small amounts of B₁₂ in supplements such as multivitamins, since it is not bound to proteins, as is the B₁₂ in foods. ^[127] Some infections such as giardiasis, ^[129] and diphyllobothriasis caused by parasites can also cause malabsorption. Impaired absorption can also result from blind loop syndrome where an overpopulation of bacteria in the small intestine absorb the vitamin. ^[126] B₁₂ deficiency caused by Helicobacter pylori was positively correlated with CagA positivity and gastric inflammatory activity, rather than gastric atrophy. ^[130]
• Medications: long-term use of certain medications can result in poor absorption of dietary vitamin B₁₂. ^[1] These include medications to treat heartburn, and metformin to treat diabetes. ^{[131] [132]}
• A genetic disorder, transcobalamin II deficiency, or Imerslund–Gräsbeck syndrome can be a cause.
• Nitrous oxide exposure, and recreational use. ^[133]

Inadequate intake

Vitamin B₁₂ cannot be produced by the human body, and must be obtained from the diet. ^[2] The body normally gets enough vitamin B₁₂ from the consumption of foods from animal sources. ^[2] Inadequate dietary intake of animal products such as eggs, meat, milk, fish, fowl (and some type of edible algae) can result in a deficiency state. ^[134] Vegans, and to a lesser degree vegetarians, are at risk for B₁₂ deficiency if they do not consume either a dietary supplement or vitamin-fortified foods. Children are at a higher risk for B₁₂ deficiency due to inadequate dietary intake, as they have fewer vitamin stores and a relatively larger vitamin need per calorie of food intake. ^[135]

Increased need

Increased needs by the body can occur due to AIDS and hemolysis (the breakdown of red blood cells), which stimulates increased red cell production. ^[1]

Mechanism

MRI image of the brain in vitamin B₁₂ deficiency, axial view showing the "precontrast FLAIR image": note the abnormal lesions (circled) in the periventricular area suggesting white matter pathology.

Physiology

The total amount of vitamin B₁₂ stored in the body is between two and five milligrams in adults. Approximately 50% is stored in the liver, but approximately 0.1% is lost each day, due to secretions into the gut –not all of the vitamin in the gut is reabsorbed. While bile is the main vehicle for B₁₂ excretion, most of this is recycled via enterohepatic circulation. Due to the extreme efficiency of this mechanism, the liver can store three to five years worth of vitamin B₁₂ under normal conditions and functioning. ^[136] However, the rate at which B₁₂ levels may change when dietary intake is low depends on the balance between several variables. ^[137]

The human physiology of active vitamin B₁₂ absorption from food is complex. When foods containing B₁₂ are eaten, the vitamin is usually bound to protein and is released by proteases released by the pancreas in the small intestine. Following its release, most B₁₂ is absorbed in the ileum, the last part of the small intestine, after binding to a protein known as intrinsic factor.

Pathophysiology

Further information: Vitamin B12 § Coenzyme function

Vitamin B₁₂ deficiency causes particular changes to the metabolism of two clinically relevant substances in humans:

1. Homocysteine (homocysteine to methionine, catalysed by methionine synthase) leading to hyperhomocysteinemia
2. Methylmalonic acid (methylmalonyl-CoA to succinyl-CoA, of which methylmalonyl-CoA is made from methylmalonic acid in a preceding reaction)

Methionine is activated to S-adenosyl methionine, which aids in purine and thymidine synthesis, myelin production, protein/neurotransmitters/fatty acid/phospholipid production and DNA methylation. 5-methyl tetrahydrofolate provides a methyl group, which is released to the reaction with homocysteine, resulting in methionine. This reaction requires cobalamin as a cofactor. The creation of 5-methyl tetrahydrofolate is an irreversible reaction. If B₁₂ is absent, the forward reaction of homocysteine to methionine does not occur, homocysteine concentrations increase, and the replenishment of tetrahydrofolate stops. ^[138] Because B₁₂ and folate are involved in the metabolism of homocysteine, hyperhomocysteinuria is a non-specific marker of deficiency. Methylmalonic acid is used as a test of B₁₂ deficiency, but has a low specificity.

Nervous system

Early changes include a spongiform state of neural tissue, along with edema of fibers and deficiency of tissue. The myelin decays, along with axial fiber. In later phases, fibric sclerosis of nervous tissues occurs. Those changes occur in dorsal parts of the spinal cord and to pyramidal tracts in lateral cords and are called subacute combined degeneration of spinal cord. ^[139] Pathological changes can be noticed as well in the posterior roots of the cord and, to lesser extent, in peripheral nerves.

In the brain itself, changes are less severe: They occur as small sources of nervous fibers decay and accumulation of astrocytes, usually subcortically located, and also round hemorrhages with a torus of glial cells.

MRI of the brain may show periventricular white matter abnormalities. MRI of the spinal cord may show linear hyperintensity in the posterior portion of the cervical tract of the spinal cord, with selective involvement of the posterior columns.

Diagnosis

Schematic representation of the propionate metabolic pathway. Methylmalonyl-CoA mutase requires the coenzyme adenosylcobalamin in order to convert L-methylmalonyl-CoA into succinyl-CoA. Otherwise, methylmalonic acid accumulates, which can be a marker for vitamin B₁₂ deficiency, among other things.

A diagnosis of vitamin B₁₂ deficiency is determined by blood levels lower than 200 or 250 picograms per ml (148 or 185 picomoles per liter). Measurement of blood methylmalonic acid (MMA), a vitamin B₁₂-associated metabolite, is a commonly used biomarker. ^[2] Deficiency is often suspected first, as diagnosis usually requires several tests. ^{[2] [140]} There is no gold standard assay to confirm a vitamin B₁₂ deficiency. ^[141]

Blood tests may show low levels of vitamin B₁₂, elevated levels of methylmalonic acid or homocysteine, and a routine complete blood counts may shows anemia with an elevated mean cell volume. ^[140] The presence of antibodies to gastric parietal cells and intrinsic factor may indicate pernicious anemia. ^[2]

Deficiency can develop without anemia or within normal vitamin B₁₂ levels, leading to a methylmalonic acid or homocysteine assay. ^{[2] [4] [142] [143]} In some cases, a peripheral blood smear may be used; which may allow to show macrocytes and hypersegmented polymorphonuclear leukocytes. ^[140] Neuropsychiatric symptoms can precede hematological signs and are often the presenting manifestation of B₁₂ deficiency. ^[144] Anemia can be prevented or masked by folic acid in which activate tetrahydrofolate (THF) needed for DNA synthesis. ^[145]

However, elevated methylmalonic acid levels may also be related to metabolic disorders such as methylmalonic acidemia. If elevated methylmalonic acid levels are further accompanied by elevated malonic acid levels, this may be indicative of combined malonic and methylmalonic aciduria (CMAMMA). ^[146]

If nervous system damage is present and blood testing is inconclusive, a lumbar puncture to measure cerebrospinal fluid B-₁₂ levels may be done. ^[147] On bone marrow aspiration or biopsy, megaloblasts are seen. ^[148]

The Schilling test was a radio-isotope method, now outdated, of testing for low vitamin B₁₂. ^{[140] [149]}

Serum levels

Further information: Reference ranges for blood tests § Vitamins

A blood test shows vitamin B₁₂ levels in the blood. Vitamin B₁₂ deficiency can be determined, but not always. ^[14] This means it measures forms of vitamin B₁₂ that are "active" and can be used by the body, as well as the "inactive" forms, which cannot. ^[150] Vitamin B₁₂ deficiency can be found within normal levels, so clinical symptoms should be taken into account when a diagnosis is made. ^[2] Normal blood levels are considered to be at least above 300 pg/mL in adults. ^[2] Some researchers have suggested that current standards for vitamin B₁₂ levels are too low. ^[151]

Treatment

Hydroxocobalamin injection is a clear red liquid solution.

Treatment should take into account the cause and severity of the condition. ^[6] Treatment is done by vitamin B₁₂ supplementation, either by mouth or by injection. ^[3] Initially in high daily doses, followed by less frequent lower doses, as the condition improves. ^[3] If a reversible cause is found, that cause should be corrected if possible. ^[11] If no reversible cause is found, or when found it cannot be eliminated, lifelong vitamin B₁₂ administration is usually recommended. ^[12] More serious vitamin B₁₂ deficiency requires injections initially. ^[3] A 2019 study suggested that oral B₁₂ is inferior to B₁₂ injections in severe cases, as "there is no proof in large prospective, double-blind studies that oral supplementation is as effective in reducing symptoms associated with vitamin B₁₂ deficiency as parenteral treatment." ^[152]

There is risk that folic acid administered to those with untreated B₁₂ deficiency may mask anemia without solving the issue at hand in which, if left untreated, can cause lasting serious side effects that affect the nervous system and brain. ^[153]

Measuring vitamin B₁₂ values during or after treatment, in order to measure the effectiveness of treatment, is useless. ^[154]

Epidemiology

Vitamin B₁₂ deficiency is common and occurs worldwide. In the US and UK, around 6 percent of the general population have the deficiency; in those over the age of sixty, around 20 percent are deficient. In under-developed countries, the rates are even higher: across Latin America 40 percent are deficient; in some parts of Africa, 70 percent; and in some parts of India, 70 to 80 percent. ^[1]

According to the World Health Organization (WHO), vitamin B₁₂ deficiency may be considered a global public health problem affecting millions of individuals. ^[155] However, the incidence and prevalence of vitamin B₁₂ deficiency worldwide is unknown due to the limited population-based data available (see table below).

Developed countries such as the United States, Germany and the United Kingdom have relatively constant mean vitamin B₁₂ concentrations. ^[156] The data from the National Health and Nutrition Examination Survey (NHANES) reported the prevalence of serum vitamin B₁₂ concentrations in the United States population between 1999 and 2002. ^{[157] [158]} Serum vitamin B₁₂ concentrations of < 148 pmol/L was present in < 1% of children and adolescents. In adults aged 20–39 years, concentrations were below this cut-off in ≤ 3% of individuals. In the elderly (70 years and older), ≈ 6% of persons had a vitamin B₁₂ concentration below the cut-off.

Furthermore, ≈ 14–16% of adults and > 20% of elderly individuals showed evidence of marginal vitamin B₁₂ depletion (serum vitamin B₁₂: 148–221 pmol/L). ^{[157] [158]} In the United Kingdom, a National Diet and Nutrition Survey (NDNS) was conducted in adults aged between 19 and 64 years in 2000–2001 ^[159] and in elderly individuals (≥ 65 years) in 1994–95. ^[160] Six percent of men (n = 632) and 10% of women (n = 667) had low serum vitamin B₁₂ concentrations, defined as < 150 pmol/L. In a subgroup of women of reproductive age (19 to 49 years), 11% had low serum B₁₂ concentrations < 150 pmol/L (n = 476). The prevalence of vitamin B₁₂ deficiency increased substantially in the elderly, where 31% of the elderly had vitamin B₁₂ levels below 130 pmol/L. In the most recent NDNS survey conducted between 2008 and 2011, serum vitamin B₁₂ was measured in 549 adults. ^[161] The mean serum vitamin B₁₂ concentration for men (19–64 years) was 308 pmol/L, of which 0.9% of men had low serum B₁₂ concentrations < 150 pmol/L. In women aged between 19 and 64 years, the mean serum vitamin B₁₂ concentration was slightly lower than men (298 pmol/L), with 3.3% having low vitamin B₁₂ concentrations < 150 pmol/L. ^[161] In Germany, a national survey in 1998 was conducted in 1,266 women of childbearing age. Approximately, 14.7% of these women had mean serum vitamin B₁₂ concentrations of < 148 pmol/L. ^[162]

Few studies have reported vitamin B₁₂ status on a national level in non-Western countries. ^[163] Of these reported studies, vitamin B₁₂ deficiency was prevalent among school-aged children in Venezuela (11.4%), ^[164] children aged 1–6 years in Mexico (7.7%), ^[165] women of reproductive age in Vietnam (11.7%), ^[166] pregnant women in Venezuela (61.34%) ^[164] and in the elderly population (> 65 years) in New Zealand (12%). ^[167] Currently, there are no nationally representative surveys for any African or South Asian countries. However, the very few surveys which have investigated vitamin B₁₂ deficiency in these countries have been based on local or district level data. These surveys have reported a high prevalence of vitamin B₁₂ deficiency (< 150 pmol/L), among 36% of breastfed and 9% of non-breastfed children (n = 2482) in New Delhi ^[168] and 47% of adults (n = 204) ^[169] in Pune, Maharashtra, India. Furthermore, in Kenya a local district survey in Embu (n = 512) revealed that 40% of school-aged children in Kenya had vitamin B₁₂ deficiency. ^[170]

Worldwide prevalence of vitamin B₁₂ deficiency (serum/plasma B₁₂ < 148 or 150 pmol/L)

Group	Number of studies	Number of participants	Vitamin B12 deficiency (%)
Children (< 1y – 18 years)	14	22,331	12.5
Pregnant women	11	11,381	27.5
Non-pregnant women	16	18,520	16
All adults (under 60 years)	18	81.438	6
Elderly (60+ years)	25	30,449	19

Derived from Table 2 available on ^[171]

History

Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy. ^[172] During the 1920s, George Whipple discovered that ingesting large amounts of liver seemed to most rapidly cure the anemia of blood loss in dogs, and hypothesized that eating liver might treat pernicious anemia. ^[173] Edwin Cohn prepared a liver extract that was 50 to 100 times more potent in treating pernicious anemia than the natural liver products. William Castle demonstrated that gastric juice contained an "intrinsic factor" which when combined with meat ingestion resulted in absorption of the vitamin in this condition. ^[172] In 1934, George Whipple shared the 1934 Nobel Prize in Physiology or Medicine with William P. Murphy and George Minot for discovery of an effective treatment for pernicious anemia using liver concentrate, later found to contain a large amount of vitamin B₁₂. ^{[172] [174]}

Other animals

Ruminants, such as cattle and sheep, absorb B₁₂ synthesized by their gut bacteria. Sufficient amounts of cobalt and copper need to be consumed for this B₁₂ synthesis to occur. ^[175]

In the early 20th century, during the development for farming of the North Island Volcanic Plateau of New Zealand, cattle had what was termed "bush sickness". It was discovered in 1934 that the volcanic soils lacked the cobalt salts essential for synthesis of vitamin B₁₂ by their gut bacteria. ^{[176] [175]} The "coast disease" of sheep in the coastal sand dunes of South Australia in the 1930s was found to originate in nutritional deficiencies of the trace elements, cobalt and copper. The cobalt deficiency was overcome by the development of "cobalt bullets", dense pellets of cobalt oxide mixed with clay given orally, which then was retained in the animal's rumen. ^{[175] [177]}

References

1. Hunt A, Harrington D, Robinson S (September 2014). "Vitamin B12 deficiency" (PDF). BMJ. 349: g5226. doi:10.1136/bmj.g5226. PMID   25189324. S2CID   28782021. Archived from the original (PDF) on March 12, 2017.
2. "Vitamin B₁₂ – Fact Sheet for Health Professionals". National Institutes of Health, Office of Dietary Supplements. December 22, 2022. Retrieved February 28, 2023.
3. Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH (March 2018). "Oral vitamin B₁₂ versus intramuscular vitamin B₁₂ for vitamin B₁₂ deficiency". The Cochrane Database of Systematic Reviews. 2018 (3): CD004655. doi:10.1002/14651858.CD004655.pub3. PMC   5112015 . PMID   29543316.
4. Langan RC, Goodbred AJ (September 2017). "Vitamin B12 Deficiency: Recognition and Management". American Family Physician. 96 (6): 384–389. PMID   28925645.
5. Herrmann W (2011). Vitamins in the prevention of human diseases. Berlin: Walter de Gruyter. p. 245. ISBN   978-3-11-021448-2.
6. "Pernicious Anemia Clinical Presentation: History, Physical Examination". September 14, 2017. Archived from the original on September 14, 2017. Retrieved November 28, 2021.
7. "Vitamin B12 or folate deficiency anaemia – Complications". NHS UK. November 18, 2021.
8. Azzini E, Raguzzini A, Polito A (September 2021). "A Brief Review on Vitamin B₁₂ Deficiency Looking at Some Case Study Reports in Adults". International Journal of Molecular Sciences. 22 (18): 9694. doi: 10.3390/ijms22189694 . PMC   8471716 . PMID   34575856.
9. Miller JW (July 2018). "Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications". Advances in Nutrition. 9 (4): 511S–518S. doi:10.1093/advances/nmy023. PMC   6054240 . PMID   30032223.
10. Hamilton MS, Blackmore S, Lee A (May 14, 2022). "Further cases of false normal B₁₂ assays – intrinsic factor antibody interference a possible mechanism?". BMJ.
11. Hankey GJ, Wardlaw JM (2008). Clinical neurology. London: Manson. p. 466. ISBN   978-1-84076-518-2.
12. Schwartz W (2012). The 5-minute pediatric consult (6th ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 535. ISBN   978-1-4511-1656-4.
13. Kim J, Kim MJ, Kho HS (May 2016). "Oral manifestations in vitamin B12 deficiency patients with or without history of gastrectomy". BMC Oral Health. 16 (1): 60. doi: 10.1186/s12903-016-0215-y . PMC   4884371 . PMID   27234214.
14. Scarpa E, Candiotto L, Sartori R, Radossi P, Maschio N, Tagariello G (October 2013). "Undetected vitamin B12 deficiency due to false normal assay results". Blood Transfusion = Trasfusione del Sangue. 11 (4): 627–629. doi:10.2450/2012.0183-12. PMC   3827408 . PMID   23356970.
15. "Vitamin B₁₂ Deficiency – Disorders of Nutrition". MSD Manual Consumer Version. Retrieved October 15, 2021.
16. "Vitamin B₁₂ Deficiency: Causes, Symptoms, and Treatment". July 28, 2021. Archived from the original on July 28, 2021. Retrieved September 13, 2021.
17. Reynolds EH (2014). "The neurology of folic acid deficiency". In Biller J, Ferro JM (eds.). Neurologic aspects of systemic disease. Handbook of Clinical Neurology. Vol. 120. pp. 927–943. doi:10.1016/B978-0-7020-4087-0.00061-9. ISBN   978-0-7020-4087-0. PMID   24365361.
18. "Vitamin B₁₂ Deficiency Anemia | Michigan Medicine". www.uofmhealth.org. Retrieved October 8, 2021.
19. "How a Vitamin B Deficiency Affects Blood Pressure". Livestrong.comlanguage=en. Retrieved September 13, 2021.
20. "Vitamin B₁₂ or folate deficiency anaemia". HSE.ie. Retrieved December 5, 2021.
21. "Articles". Cedars-Sinai. Archived from the original on May 30, 2020. Retrieved September 13, 2021.
22. Harvard Health Publishing Staff (January 10, 2013). "Vitamin B₁₂ deficiency can be sneaky, harmful". Harvard Health. Retrieved March 11, 2022.
23. Li K, McKay G (March 2000). "Images in clinical medicine. Ischemic retinopathy caused by severe megaloblastic anemia". The New England Journal of Medicine. 342 (12): 860. doi:10.1056/NEJM200003233421205. PMID   10727590.
24. Qudsiya Z, De Jesus O (2022). "Subacute Combined Degeneration of the Spinal Cord". StatPearls. StatPearls Publishing. PMID   32644742 . Retrieved February 19, 2022.
25. Tsoriev A. "Subacute combined degeneration of the cord (funicular myelosis) | Radiology Case | Radiopaedia.org". Radiopaedia. Retrieved February 5, 2022.
26. Dudorova EY, Damulin IV, Khatkov IE (2015). "[Neurological complications due to vitamin deficiencies after bariatric surgery]". Terapevticheskii Arkhiv. 87 (12): 117–121. doi: 10.17116/terarkh20158712117-121 . PMID   27035000.
27. Hasbaoui BE, Mebrouk N, Saghir S, Yajouri AE, Abilkassem R, Agadr A (2021). "Vitamin B12 deficiency: case report and review of literature". The Pan African Medical Journal. 38: 237. doi:10.11604/pamj.2021.38.237.20967 (inactive November 1, 2024). PMC   8140678 . PMID   34046142.
28. Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D (April 2012). "Cognitive impairment and vitamin B12: a review". International Psychogeriatrics. 24 (4): 541–556. doi:10.1017/S1041610211002511. PMID   22221769. S2CID   206300763.
29. Zempleni J, Suttie JW, Gregory III JF, Stover PJ, eds. (2014). Handbook of vitamins (Fifth ed.). Hoboken: CRC Press. p. 477. ISBN   978-1-4665-1557-4. Archived from the original on August 17, 2016.
30. O'Gorman P, Holmes D, Ramanan AV, Bose-Haider B, Lewis MJ, Will A (June 2002). "Dietary vitamin B12 deficiency in an adolescent white boy". Journal of Clinical Pathology. 55 (6): 475–476. doi:10.1136/jcp.55.6.475. PMC   1769668 . PMID   12037034.
31. Briani C, Dalla Torre C, Citton V, Manara R, Pompanin S, Binotto G, et al. (November 2013). "Cobalamin deficiency: clinical picture and radiological findings". Nutrients. 5 (11): 4521–4539. doi: 10.3390/nu5114521 . PMC   3847746 . PMID   24248213.
32. "Watermelon stomach | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved February 18, 2022.
33. Amarapurka DN, Patel ND (September 2004). "Gastric Antral Vascular Ectasia (GAVE) Syndrome" (PDF). Journal of the Association of Physicians of India. 52: 757. Archived (PDF) from the original on March 4, 2016.
34. Matsumoto A, Shiga Y, Shimizu H, Kimura I, Hisanaga K (April 2009). "[Encephalomyelopathy due to vitamin B12 deficiency with seizures as a predominant symptom]". Rinsho Shinkeigaku = Clinical Neurology. 49 (4): 179–185. doi: 10.5692/clinicalneurol.49.179 . PMID   19462816.
35. Kumar S (March 2004). "Recurrent seizures: an unusual manifestation of vitamin B12 deficiency". Neurology India. 52 (1): 122–123. PMID   15069260. Archived from the original on January 23, 2011.
36. Kliegman RM, Stanton BF, St Geme J (2016). Kliegman RM, Stanton B, St Geme J, Schor NF (eds.). Nelson Textbook of Pediatrics (20th ed.). Elsevier Health Sciences. pp. 2319–2326. ISBN   978-1-4557-7566-8.
37. Black MM (June 2008). "Effects of vitamin B12 and folate deficiency on brain development in children". Food and Nutrition Bulletin. 29 (2 Suppl): S126–S131. doi:10.1177/15648265080292S117. PMC   3137939 . PMID   18709887.
38. Knight BA, Shields BM, Brook A, Hill A, Bhat DS, Hattersley AT, et al. (August 19, 2015). Sengupta S (ed.). "Lower Circulating B12 Is Associated with Higher Obesity and Insulin Resistance during Pregnancy in a Non-Diabetic White British Population". PLOS ONE. 10 (8): e0135268. Bibcode:2015PLoSO..1035268K. doi: 10.1371/journal.pone.0135268 . PMC   4545890 . PMID   26288227.
39. "Erratum for Sukumar N et al. Prevalence of vitamin B-12 insufficiency during pregnancy and its effect on offspring birth weight: a systematic review and meta-analysis. Am J Clin Nutr 2016; 103:1232–1251". The American Journal of Clinical Nutrition. 105 (1): 241.1–241. January 2017. doi: 10.3945/ajcn.116.148585 . PMID   28049667.
40. Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ, et al. (January 2008). "Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study". Diabetologia. 51 (1): 29–38. doi:10.1007/s00125-007-0793-y. PMC   2100429 . PMID   17851649.
41. Krishnaveni GV, Hill JC, Veena SR, Bhat DS, Wills AK, Karat CL, et al. (November 2009). "Low plasma vitamin B12 in pregnancy is associated with gestational 'diabesity' and later diabetes". Diabetologia. 52 (11): 2350–2358. doi: 10.1007/s00125-009-1499-0 . PMC   3541499 . PMID   19707742.
42. Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, et al. (December 2007). "DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status". Proceedings of the National Academy of Sciences of the United States of America. 104 (49): 19351–19356. Bibcode:2007PNAS..10419351S. doi: 10.1073/pnas.0707258104 . PMC   2148293 . PMID   18042717.
43. Finer S, Saravanan P, Hitman G, Yajnik C (March 2014). "The role of the one-carbon cycle in the developmental origins of Type 2 diabetes and obesity". Diabetic Medicine. 31 (3): 263–272. doi:10.1111/dme.12390. PMID   24344881. S2CID   36014480.
44. Krikke GG, Grooten IJ, Vrijkotte TG, van Eijsden M, Roseboom TJ, Painter RC (February 2016). "Vitamin B12 and folate status in early pregnancy and cardiometabolic risk factors in the offspring at age 5–6 years: findings from the ABCD multi-ethnic birth cohort". BJOG. 123 (3): 384–392. doi:10.1111/1471-0528.13574. PMID   26810674. S2CID   1822164.
45. Adaikalakoteswari A, Vatish M, Alam MT, Ott S, Kumar S, Saravanan P (November 2017). "Low Vitamin B12 in Pregnancy Is Associated With Adipose-Derived Circulating miRs Targeting PPARγ and Insulin Resistance". The Journal of Clinical Endocrinology and Metabolism. 102 (11): 4200–4209. doi: 10.1210/jc.2017-01155 . PMID   28938471.
46. Chango A, Pogribny IP (April 2015). "Considering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenome". Nutrients. 7 (4): 2748–2770. doi: 10.3390/nu7042748 . PMC   4425171 . PMID   25875118.
47. Yajnik CS, Deshmukh US (June 2012). "Fetal programming: maternal nutrition and role of one-carbon metabolism". Reviews in Endocrine & Metabolic Disorders. 13 (2): 121–127. doi:10.1007/s11154-012-9214-8. PMID   22415298. S2CID   11186195.
48. Rogne T, Tielemans MJ, Chong MF, Yajnik CS, Krishnaveni GV, Poston L, et al. (February 2017). "Associations of Maternal Vitamin B12 Concentration in Pregnancy With the Risks of Preterm Birth and Low Birth Weight: A Systematic Review and Meta-Analysis of Individual Participant Data". American Journal of Epidemiology. 185 (3): 212–223. doi:10.1093/aje/kww212. PMC   5390862 . PMID   28108470.
49. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC, et al. (March 2009). "Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification". Pediatrics. 123 (3): 917–923. doi:10.1542/peds.2008-1173. hdl:2262/34511. PMC   4161975 . PMID   19255021.
50. Ray JG, Wyatt PR, Thompson MD, Vermeulen MJ, Meier C, Wong PY, et al. (May 2007). "Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population". Epidemiology. 18 (3): 362–366. doi: 10.1097/01.ede.0000257063.77411.e9 . PMID   17474166. S2CID   21094981.
51. "Maternal plasma folate and vitamin B₁₂ are independent risk factors for neural tube defects". QJM: An International Journal of Medicine. 86 (11): 703–708. November 1993. doi:10.1093/oxfordjournals.qjmed.a068749. ISSN   1460-2393.
52. Gaber, K.R., et al., Maternal vitamin B₁₂ and the risk of fetal neural tube defects in Egyptian patients. Clin Lab, 2007. 53(1–2): pp. 69–75.
53. Lövblad K, Ramelli G, Remonda L, Nirkko AC, Ozdoba C, Schroth G (February 1997). "Retardation of myelination due to dietary vitamin B12 deficiency: cranial MRI findings" (PDF). Pediatric Radiology. 27 (2): 155–158. doi:10.1007/s002470050090. PMID   9028851. S2CID   25039442.
54. Li Z, Gueant-Rodriguez RM, Quilliot D, Sirveaux MA, Meyre D, Gueant JL, et al. (October 2018). "Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity". Clinical Nutrition. 37 (5): 1700–1706. doi:10.1016/j.clnu.2017.07.008. PMID   28780990. S2CID   28557054.
55. Pinhas-Hamiel O, Doron-Panush N, Reichman B, Nitzan-Kaluski D, Shalitin S, Geva-Lerner L (September 2006). "Obese children and adolescents: a risk group for low vitamin B12 concentration". Archives of Pediatrics & Adolescent Medicine. 160 (9): 933–936. doi:10.1001/archpedi.160.9.933. PMID   16953016.
56. MacFarlane AJ, Greene-Finestone LS, Shi Y (October 2011). "Vitamin B-12 and homocysteine status in a folate-replete population: results from the Canadian Health Measures Survey". The American Journal of Clinical Nutrition. 94 (4): 1079–1087. doi: 10.3945/ajcn.111.020230 . PMID   21900461.
57. Madan AK, Orth WS, Tichansky DS, Ternovits CA (May 2006). "Vitamin and trace mineral levels after laparoscopic gastric bypass". Obesity Surgery. 16 (5): 603–606. doi:10.1381/096089206776945057. PMID   16687029. S2CID   31410788.
58. Nachtigal MC, Patterson RE, Stratton KL, Adams LA, Shattuck AL, White E (October 2005). "Dietary supplements and weight control in a middle-age population". Journal of Alternative and Complementary Medicine. 11 (5): 909–915. doi: 10.1089/acm.2005.11.909 . PMID   16296926.
59. Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aïssi D, Wahl S, et al. (June 2014). "DNA methylation and body-mass index: a genome-wide analysis". Lancet. 383 (9933): 1990–1998. doi: 10.1016/S0140-6736(13)62674-4 . PMID   24630777. S2CID   18026508.
60. Adaikalakoteswari A, Jayashri R, Sukumar N, Venkataraman H, Pradeepa R, Gokulakrishnan K, et al. (September 2014). "Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes". Cardiovascular Diabetology. 13 (1): 129. doi: 10.1186/s12933-014-0129-4 . PMC   4189588 . PMID   25283155.
61. Wall, С., Food and Nutrition Guidelines for Healthy Adolescents. Ministry of Health. Wellington, New Zealand, 1998.
62. Thomas-Valdés S, Tostes MD, Anunciação PC, da Silva BP, Sant'Ana HM (October 2017). "Association between vitamin deficiency and metabolic disorders related to obesity". Critical Reviews in Food Science and Nutrition. 57 (15): 3332–3343. doi:10.1080/10408398.2015.1117413. PMID   26745150. S2CID   19077356.
63. Debreceni B, Debreceni L (June 2014). "The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease". Cardiovascular Therapeutics. 32 (3): 130–138. doi: 10.1111/1755-5922.12064 . PMID   24571382.
64. Selhub J (July 1999). "Homocysteine metabolism". Annual Review of Nutrition. 19 (1): 217–246. doi:10.1146/annurev.nutr.19.1.217. PMID   10448523.
65. Wald DS, Law M, Morris JK (November 2002). "Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis". BMJ. 325 (7374): 1202–1206. doi:10.1136/bmj.325.7374.1202. PMC   135491 . PMID   12446535.
66. Setola E, Monti LD, Galluccio E, Palloshi A, Fragasso G, Paroni R, et al. (October 2004). "Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia". European Journal of Endocrinology. 151 (4): 483–489. doi: 10.1530/eje.0.1510483 . PMID   15476449.
67. Guven A, Inanc F, Kilinc M, Ekerbicer H (November 2005). "Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome". Heart and Vessels. 20 (6): 290–295. doi:10.1007/s00380-004-0822-4. PMID   16314912. S2CID   19304098.
68. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, et al. (October 2005). "Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis" (PDF). JAMA. 294 (14): 1799–1809. doi:10.1001/jama.294.14.1799. PMID   16219884. S2CID   6128916.
69. Welsh P, Lowe GD, Chalmers J, Campbell DJ, Rumley A, Neal BC, et al. (August 2008). "Associations of proinflammatory cytokines with the risk of recurrent stroke". Stroke. 39 (8): 2226–2230. doi: 10.1161/STROKEAHA.107.504498 . PMID   18566306.
70. Wiebe N, Field CJ, Tonelli M (November 2018). "A systematic review of the vitamin B12, folate and homocysteine triad across body mass index". Obesity Reviews. 19 (11): 1608–1618. doi:10.1111/obr.12724. PMID   30074676. S2CID   51908596.
71. Mahabir S, Ettinger S, Johnson L, Baer DJ, Clevidence BA, Hartman TJ, et al. (May 2008). "Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study". European Journal of Clinical Nutrition. 62 (5): 644–650. doi:10.1038/sj.ejcn.1602771. PMC   3236439 . PMID   17457338.
72. Reitman A, Friedrich I, Ben-Amotz A, Levy Y (August 2002). "Low plasma antioxidants and normal plasma B vitamins and homocysteine in patients with severe obesity". The Israel Medical Association Journal. 4 (8): 590–593. PMID   12183861.
73. Zhu W, Huang X, Li M, Neubauer H (May 2006). "Elevated plasma homocysteine in obese schoolchildren with early atherosclerosis". European Journal of Pediatrics. 165 (5): 326–331. doi:10.1007/s00431-005-0033-8. PMID   16344991. S2CID   24549104.
74. Aasheim ET, Hofsø D, Hjelmesaeth J, Birkeland KI, Bøhmer T (February 2008). "Vitamin status in morbidly obese patients: a cross-sectional study". The American Journal of Clinical Nutrition. 87 (2): 362–369. doi: 10.1093/ajcn/87.2.362 . PMID   18258626.
75. Damião CP, Rodrigues AO, Pinheiro MF, Cruz RA, Cardoso GP, Taboada GF, et al. (June 3, 2016). "Prevalence of vitamin B12 deficiency in type 2 diabetic patients using metformin: a cross-sectional study". Sao Paulo Medical Journal = Revista Paulista de Medicina. 134 (6): 473–479. doi: 10.1590/1516-3180.2015.01382111 . PMC   11448733 . PMID   28076635.
76. Akabwai GP, Kibirige D, Mugenyi L, Kaddu M, Opio C, Lalitha R, et al. (December 2015). "Vitamin B12 deficiency among adult diabetic patients in Uganda: relation to glycaemic control and haemoglobin concentration". Journal of Diabetes and Metabolic Disorders. 15 (1): 26. doi: 10.1186/s40200-016-0250-x . PMC   4962419 . PMID   27468410.
77. Kaya C, Cengiz SD, Satiroğlu H (November 2009). "Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS". Reproductive Biomedicine Online. 19 (5): 721–726. doi:10.1016/j.rbmo.2009.06.005. PMID   20021721.
78. Iglesia I, González-Gross M, Huybrechts I, De Miguel-Etayo P, Molnar D, Manios Y, et al. (June 2017). "[Associations between insulin resistance and three B-vitamins in European adolescents: the HELENA study]". Nutricion Hospitalaria. 34 (3): 568–577. doi: 10.20960/nh.559 (inactive November 1, 2024). hdl: 1854/LU-8731273 . PMID   28627191.
79. Jayashri R, Venkatesan U, Rohan M, Gokulakrishnan K, Shanthi Rani CS, Deepa M, et al. (December 2018). "Prevalence of vitamin B₁₂ deficiency in South Indians with different grades of glucose tolerance". Acta Diabetologica. 55 (12): 1283–1293. doi:10.1007/s00592-018-1240-x. PMID   30317438. S2CID   52977621.
80. Vayá A, Rivera L, Hernández-Mijares A, de la Fuente M, Solá E, Romagnoli M, et al. (2012). "Homocysteine levels in morbidly obese patients: its association with waist circumference and insulin resistance". Clinical Hemorheology and Microcirculation. 52 (1): 49–56. doi:10.3233/CH-2012-1544. PMID   22460264.
81. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP (February 2012). "Association of biochemical B₁₂ deficiency with metformin therapy and vitamin B₁₂ supplements: the National Health and Nutrition Examination Survey, 1999–2006". Diabetes Care. 35 (2): 327–333. doi:10.2337/dc11-1582. PMC   3263877 . PMID   22179958.
82. Hampel H, Abraham NS, El-Serag HB (August 2005). "Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications". Annals of Internal Medicine. 143 (3): 199–211. doi:10.7326/0003-4819-143-3-200508020-00006. PMID   16061918. S2CID   15540274.
83. Rafnsson SB, Saravanan P, Bhopal RS, Yajnik CS (March 2011). "Is a low blood level of vitamin B12 a cardiovascular and diabetes risk factor? A systematic review of cohort studies". European Journal of Nutrition. 50 (2): 97–106. doi:10.1007/s00394-010-0119-6. PMID   20585951. S2CID   28405065.
84. Jayedi A, Zargar MS (September 8, 2019). "Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies". Critical Reviews in Food Science and Nutrition. 59 (16): 2697–2707. doi:10.1080/10408398.2018.1511967. PMID   30431328. S2CID   53430399.
85. Metz J (June 2008). "A high prevalence of biochemical evidence of vitamin B12 or folate deficiency does not translate into a comparable prevalence of anemia". Food and Nutrition Bulletin. 29 (2 Suppl): S74–S85. doi:10.1177/15648265080292S111. PMID   18709883. S2CID   24852101.
86. Edelstein T, Stevens K, Baumslag N, Metz J (February 1968). "Folic acid and vitamin B12 supplementation during pregnancy in a population subsisting on a suboptimal diet". The Journal of Obstetrics and Gynaecology of the British Commonwealth. 75 (2): 133–137. doi:10.1111/j.1471-0528.1968.tb02022.x. PMID   5641006. S2CID   45266873.
87. Shahab-Ferdows, S., Randomized Placebo-controlled Vitamin B₁₂ Supplementation Trial in Deficient Rural Mexican Women: Baseline Assessment, Transcobalamin Genotype and Response of Biochemical and Functional Markers to Supplementation. 2007: University of California, Davis.
88. Reid, E.D., et al., Hematological and biochemical responses of rural Mexican preschoolers to iron alone or iron plus micronutrients. Vol. 15. 2001. A731.
89. O'Leary F, Samman S (March 2010). "Vitamin B12 in health and disease". Nutrients. 2 (3): 299–316. doi: 10.3390/nu2030299 . PMC   3257642 . PMID   22254022.
90. Foran S, Wang JJ, Mitchell P (October 2003). "Causes of visual impairment in two older population cross-sections: the Blue Mountains Eye Study". Ophthalmic Epidemiology. 10 (4): 215–225. doi:10.1076/opep.10.4.215.15906. PMID   14628964. S2CID   29358674.
91. Pennington KL, DeAngelis MM (December 2016). "Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors". Eye and Vision. 3 (1): 34. doi: 10.1186/s40662-016-0063-5 . PMC   5178091 . PMID   28032115.
92. Al-Zamil WM, Yassin SA (August 2017). "Recent developments in age-related macular degeneration: a review". Clinical Interventions in Aging. 12: 1313–1330. doi: 10.2147/CIA.S143508 . PMC   5573066 . PMID   28860733.
93. Kamburoglu G, Gumus K, Kadayifcilar S, Eldem B (May 2006). "Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration". Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie. 244 (5): 565–569. doi:10.1007/s00417-005-0108-2. PMID   16163497. S2CID   25236215.
94. Rochtchina E, Wang JJ, Flood VM, Mitchell P (February 2007). "Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye Study". American Journal of Ophthalmology. 143 (2): 344–346. doi:10.1016/j.ajo.2006.08.032. PMID   17258528.
95. Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE (February 2009). "Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study". Archives of Internal Medicine. 169 (4): 335–341. doi:10.1001/archinternmed.2008.574. PMC   2648137 . PMID   19237716.
96. Heuberger RA, Fisher AI, Jacques PF, Klein R, Klein BE, Palta M, et al. (October 2002). "Relation of blood homocysteine and its nutritional determinants to age-related maculopathy in the third National Health and Nutrition Examination Survey". The American Journal of Clinical Nutrition. 76 (4): 897–902. doi: 10.1093/ajcn/76.4.897 . PMID   12324306.
97. Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. (June 2013). "Frailty consensus: a call to action". Journal of the American Medical Directors Association. 14 (6): 392–397. doi:10.1016/j.jamda.2013.03.022. PMC   4084863 . PMID   23764209.
98. Vermeiren S, Vella-Azzopardi R, Beckwée D, Habbig AK, Scafoglieri A, Jansen B, et al. (December 2016). "Frailty and the Prediction of Negative Health Outcomes: A Meta-Analysis". Journal of the American Medical Directors Association. 17 (12): 1163.e1–1163.e17. doi:10.1016/j.jamda.2016.09.010. PMID   27886869.
99. Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R, et al. (November 2016). "Inflammation and frailty in the elderly: A systematic review and meta-analysis". Ageing Research Reviews. 31: 1–8. doi: 10.1016/j.arr.2016.08.006 . hdl: 10447/463258 . PMID   27592340. S2CID   460021.
100. O'Leary F, Flood VM, Petocz P, Allman-Farinelli M, Samman S (June 2011). "B vitamin status, dietary intake and length of stay in a sample of elderly rehabilitation patients". The Journal of Nutrition, Health & Aging. 15 (6): 485–489. doi: 10.1007/s12603-010-0330-4 . PMID   21623471. S2CID   23887493.
101. Matteini AM, Walston JD, Fallin MD, Bandeen-Roche K, Kao WH, Semba RD, et al. (May 2008). "Markers of B-vitamin deficiency and frailty in older women". The Journal of Nutrition, Health & Aging. 12 (5): 303–308. doi:10.1007/BF02982659. PMC   2739594 . PMID   18443711.
102. Hunt A, Harrington D, Robinson S (September 2014). "Vitamin B12 deficiency". BMJ. 349 (sep04 1): g5226. doi:10.1136/bmj.g5226. PMID   25189324. S2CID   28782021.
103. Quadros EV (January 2010). "Advances in the understanding of cobalamin assimilation and metabolism". British Journal of Haematology. 148 (2): 195–204. doi:10.1111/j.1365-2141.2009.07937.x. PMC   2809139 . PMID   19832808.
104. Gröber U, Kisters K, Schmidt J (December 2013). "Neuroenhancement with vitamin B12-underestimated neurological significance". Nutrients. 5 (12): 5031–5045. doi: 10.3390/nu5125031 . PMC   3875920 . PMID   24352086.
105. Holmes JM (December 15, 1956). "Cerebral Manifestations of Vitamin-B12 Deficiency". Br Med J. 2 (5006): 1394–1398. doi:10.1136/bmj.2.5006.1394. ISSN   0007-1447. PMC   2035923 . PMID   13374343.
106. Ralapanawa DM, Jayawickreme KP, Ekanayake EM, Jayalath WA (September 2015). "B12 deficiency with neurological manifestations in the absence of anaemia". BMC Research Notes. 8 (1): 458. doi: 10.1186/s13104-015-1437-9 . PMC   4575440 . PMID   26385097.
107. Rosenberg IH (June 2008). "Effects of folate and vitamin B12 on cognitive function in adults and the elderly". Food and Nutrition Bulletin. 29 (2 Suppl): S132–S142. doi: 10.1177/15648265080292S118 . PMID   18709888. S2CID   1509549.
108. Smith AD, Refsum H (February 2009). "Vitamin B-12 and cognition in the elderly". The American Journal of Clinical Nutrition. 89 (2): 707S–711S. doi: 10.3945/ajcn.2008.26947D . PMID   19116332.
109. Lewis MS, Miller LS, Johnson MA, Dolce EB, Allen RH, Stabler SP (April 14, 2005). "Elevated methylmalonic acid is related to cognitive impairement in older adults enrolled in an elderly nutrition program". Journal of Nutrition for the Elderly. 24 (3): 47–65. doi:10.1300/J052v24n03_05. PMID   15911524. S2CID   37997967.
110. McCully KS (November 2007). "Homocysteine, vitamins, and vascular disease prevention". The American Journal of Clinical Nutrition. 86 (5): 1563S–1568S. doi: 10.1093/ajcn/86.5.1563S . PMID   17991676.
111. Malouf R, Areosa Sastre A, et al. (The Cochrane Collaboration) (July 21, 2003). "Vitamin B12 for cognition". The Cochrane Database of Systematic Reviews (3). Chichester, UK: John Wiley & Sons, Ltd: CD004326. doi:10.1002/14651858.cd004326. PMID   12918012.
112. Vogiatzoglou A, Refsum H, Johnston C, Smith SM, Bradley KM, de Jager C, et al. (September 2008). "Vitamin B12 status and rate of brain volume loss in community-dwelling elderly". Neurology. 71 (11): 826–832. doi:10.1212/01.wnl.0000325581.26991.f2. PMID   18779510. S2CID   22192911.
113. Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA (June 2005). "Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people". Journal of Bone and Mineral Research. 20 (6): 921–929. doi:10.1359/JBMR.050202. PMID   15883631. S2CID   11881415.
114. Tucker KL, Hannan MT, Qiao N, Jacques PF, Selhub J, Cupples LA, et al. (January 2005). "Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study". Journal of Bone and Mineral Research. 20 (1): 152–158. doi:10.1359/JBMR.041018. PMID   15619681. S2CID   33994229.
115. Herrmann M, Peter Schmidt J, Umanskaya N, Wagner A, Taban-Shomal O, Widmann T, et al. (January 1, 2007). "The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review". Clinical Chemistry and Laboratory Medicine. 45 (12): 1621–1632. doi:10.1515/CCLM.2007.362. PMID   18067447. S2CID   7641257.
116. Morris MS, Jacques PF, Selhub J (August 2005). "Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans". Bone. 37 (2): 234–242. doi:10.1016/j.bone.2005.04.017. PMID   15950558.
117. Carmel R, Lau KH, Baylink DJ, Saxena S, Singer FR (July 1988). "Cobalamin and osteoblast-specific proteins". The New England Journal of Medicine. 319 (2): 70–75. doi:10.1056/NEJM198807143190202. PMID   3260008.
118. Kim GS, Kim CH, Park JY, Lee KU, Park CS (December 1996). "Effects of vitamin B12 , on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells". Metabolism. 45 (12): 1443–1446. doi:10.1016/S0026-0495(96)90171-7. PMID   8969275.
119. Herrmann M, Umanskaya N, Traber L, Schmidt-Gayk H, Menke W, Lanzer G, et al. (January 1, 2007). "The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial". Clinical Chemistry and Laboratory Medicine. 45 (12): 1785–1792. doi:10.1515/CCLM.2007.352. PMID   18020969. S2CID   36679018.
120. Green TJ, McMahon JA, Skeaff CM, Williams SM, Whiting SJ (February 2007). "Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial". The American Journal of Clinical Nutrition. 85 (2): 460–464. doi: 10.1093/ajcn/85.2.460 . PMID   17284744.
121. Allen LH, Rosenberg IH, Oakley GP, Omenn GS (March 2010). "Considering the case for vitamin B12 fortification of flour". Food and Nutrition Bulletin. 31 (1 Suppl): S36–S46. doi:10.1177/15648265100311S104. PMID   20629351. S2CID   25738026.
122. Banka S, Ryan K, Thomson W, Newman WG (June 2011). "Pernicious anemia - genetic insights". Autoimmunity Reviews. 10 (8): 455–459. doi:10.1016/j.autrev.2011.01.009. ISSN   1873-0183. PMID   21296191.
123. Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, et al. (June 2017). "Vitamin B₁₂ deficiency". Nature Reviews. Disease Primers. 3: 17040. doi:10.1038/nrdp.2017.40. PMID   28660890. S2CID   205479529.
124. Rojas Hernandez CM, Oo TH (March 2015). "Advances in mechanisms, diagnosis, and treatment of pernicious anemia". Discovery Medicine. 19 (104): 159–168. PMID   25828519.
125. Marzinotto I, Dottori L, Baldaro F, Dilaghi E, Brigatti C, Bazzigaluppi E, et al. (2021). "Intrinsic factor autoantibodies by luminescent immuno-precipitation system in patients with corpus atrophic gastritis". Journal of Translational Autoimmunity. 4: 100131. doi:10.1016/j.jtauto.2021.100131. ISSN   2589-9090. PMC   8716657 . PMID   35005595.
126. "Blind loop syndrome: MedlinePlus Medical Encyclopedia". medlineplus.gov. Archived from the original on July 28, 2018. Retrieved February 16, 2022.
127. Baik HW, Russell RM (1999). "Vitamin B12 deficiency in the elderly". Annual Review of Nutrition. 19: 357–377. doi:10.1146/annurev.nutr.19.1.357. PMID   10448529.
128. Lam JR, Schneider JL, Zhao W, Corley DA (December 2013). "Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency". JAMA. 310 (22): 2435–2442. doi: 10.1001/jama.2013.280490 . PMID   24327038.
129. "Illness and Symptoms | Giardia | Parasites | CDC". www.cdc.gov. March 2, 2021. Retrieved February 18, 2022.
130. Ulasoglu C, Temiz HE, Sağlam ZA (2019). "The Relation of Cytotoxin-Associated Gene-A Seropositivity with Vitamin B12 Deficiency in Helicobacter pylori-Positive Patients". BioMed Research International. 2019: 1450536. doi: 10.1155/2019/1450536 . PMC   6925818 . PMID   31886171.
131. Ting RZ, Szeto CC, Chan MH, Ma KK, Chow KM (October 2006). "Risk factors of vitamin B(12) deficiency in patients receiving metformin". Archives of Internal Medicine. 166 (18): 1975–1979. doi:10.1001/archinte.166.18.1975. PMID   17030830.
132. Yeomans ND, Hanson RG, Smallwood RA, Mihaly GW, Louis WJ (July 1982). "Effect of chronic ranitidine treatment on secretion of intrinsic factor". British Medical Journal. 285 (6337): 264. doi:10.1136/bmj.285.6337.264. PMC   1499627 . PMID   6124297.
133. Kondo H, Osborne ML, Kolhouse JF, Binder MJ, Podell ER, Utley CS, et al. (May 1981). "Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats". The Journal of Clinical Investigation. 67 (5): 1270–1283. doi:10.1172/JCI110155. PMC   370693 . PMID   6112240.
134. Croft MT, Lawrence AD, Raux-Deery E, Warren MJ, Smith AG (November 2005). "Algae acquire vitamin B12 through a symbiotic relationship with bacteria". Nature. 438 (7064): 90–93. Bibcode:2005Natur.438...90C. doi:10.1038/nature04056. PMID   16267554. S2CID   4328049.
135. Rasmussen SA, Fernhoff PM, Scanlon KS (January 2001). "Vitamin B12 deficiency in children and adolescents". The Journal of Pediatrics. 138 (1): 10–17. doi:10.1067/mpd.2001.112160. PMID   11148506.
136. Voet D, Voet JG (2010). Biochemistry . New York: J. Wiley & Sons. p.  957. ISBN   978-0-470-57095-1.
137. Kazuhiro Y (2013). "Cobalt: Its Role in Health and Disease". In Sigel A, Sigel H, Sigel RK (eds.). Interrelations between Essential Metal Ions and Human Diseases. Metal Ions in Life Sciences. Vol. 13. Springer. pp. 295–320. doi:10.1007/978-94-007-7500-8_9. ISBN   978-94-007-7499-5. PMID   24470095.
138. Shane B, Stokstad EL (1985). "Vitamin B12-folate interrelationships". Annual Review of Nutrition. 5: 115–141. doi:10.1146/annurev.nu.05.070185.000555. PMID   3927946.
139. "Vitamin B₁₂ / Pathophysiology Text". LifeSave.org. p. 215. Archived from the original on February 6, 2013. Retrieved December 31, 2013.
140. Snow CF (June 1999). "Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician". Archives of Internal Medicine. 159 (12): 1289–1298. doi:10.1001/archinte.159.12.1289. PMID   10386505.
141. Herbert V, Colman N, Palat D, Manusselis C, Drivas G, Block E, et al. (November 1984). "Is there a "gold standard" for human serum vitamin B12 assay?". The Journal of Laboratory and Clinical Medicine. 104 (5): 829–841. ISSN   0022-2143. PMID   6387014.
142. Hvas AM, Nexo E (November 2006). "Diagnosis and treatment of vitamin B12 deficiency--an update". Haematologica. 91 (11): 1506–1512. PMID   17043022.
143. Devalia V, Hamilton MS, Molloy AM (August 2014). "Guidelines for the diagnosis and treatment of cobalamin and folate disorders". British Journal of Haematology. 166 (4). Wiley: 496–513. doi: 10.1111/bjh.12959 . PMID   24942828. S2CID   5772424.
144. Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, et al. (June 1988). "Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis". The New England Journal of Medicine. 318 (26): 1720–1728. doi:10.1056/NEJM198806303182604. PMID   3374544.
145. Kliegman RM, Nelson WE, eds. (2016). Nelson textbook of pediatrics: get full access and more at ExpertConsult.com (20. ed., [internat. ed.] ed.). Philadelphia, Pa: Elsevier, Saunders. ISBN   978-1-4557-7566-8.
146. de Sain-van der Velden MG, van der Ham M, Jans JJ, Visser G, Prinsen HC, Verhoeven-Duif NM, et al. (2016). Morava E, Baumgartner M, Patterson M, Rahman S (eds.). "A New Approach for Fast Metabolic Diagnostics in CMAMMA". JIMD Reports. 30. Berlin, Heidelberg: Springer Berlin Heidelberg: 15–22. doi:10.1007/8904_2016_531. ISBN   978-3-662-53680-3. PMC   5110436 . PMID   26915364.
147. Devalia V (August 2006). "Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay". BMJ. 333 (7564): 385–386. doi:10.1136/bmj.333.7564.385. PMC   1550477 . PMID   16916826.
148. "What is the role of bone marrow aspiration in the diagnosis of megaloblastic anemia?". www.medscape.com. Retrieved October 15, 2021.
149. Nickoloff E (1988). "Schilling test: physiologic basis for and use as a diagnostic test". Critical Reviews in Clinical Laboratory Sciences. 26 (4): 263–276. doi:10.3109/10408368809105892. PMID   3077032.
150. "Vitamin B12 or folate deficiency anaemia – Diagnosis". nhs.uk. October 20, 2017. Retrieved November 12, 2022.
151. Goodman M, Chen XH, Darwish D (October 1996). "Are U.S. lower normal B12 limits too low?". Journal of the American Geriatrics Society. 44 (10): 1274–1275. doi: 10.1111/j.1532-5415.1996.tb01389.x . PMID   8856015. S2CID   34014860.
152. Wolffenbuttel BH, Wouters HJ, Heiner-Fokkema MR, van der Klauw MM (June 2019). "The Many Faces of Cobalamin (Vitamin B12) Deficiency". Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 3 (2): 200–214. doi:10.1016/j.mayocpiqo.2019.03.002. ISSN   2542-4548. PMC   6543499 . PMID   31193945.
153. Malouf R, Grimley Evans J (October 8, 2008). "Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people". The Cochrane Database of Systematic Reviews (4): CD004514. doi:10.1002/14651858.CD004514.pub2. ISSN   1469-493X. PMID   18843658.
154. "Diagnosis and treatment pitfalls – B12 institute" . Retrieved April 5, 2023.
155. de Benoist B (June 2008). "Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies". Food and Nutrition Bulletin. 29 (2 Suppl): S238–S244. doi: 10.1177/15648265080292S129 . PMID   18709899.
156. Stabler SP, Allen RH (July 14, 2004). "Vitamin B12 deficiency as a worldwide problem". Annual Review of Nutrition. 24 (1): 299–326. doi:10.1146/annurev.nutr.24.012003.132440. PMID   15189123.
157. Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, et al. (September 2007). "Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004". The American Journal of Clinical Nutrition. 86 (3): 718–727. doi: 10.1093/ajcn/86.3.718 . PMID   17823438.
158. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ (August 2005). "Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999–2000". The American Journal of Clinical Nutrition. 82 (2): 442–450. doi: 10.1093/ajcn/82.2.442 . PMID   16087991.
159. Ruston D, Henderson L, Gregory J, Bates CJ, Prentice A, Birch M, et al. (2004). "National Diet and Nutrition Survey: Adults Aged 19 to 64 Years". Nutritional Status (Anthropometry and Blood Analytes), Blood Pressure and Physical Activity. 4. The Stationery Office.
160. Smithers G, Finch S, Doyle W, Lowe C, Bates CJ, Prentice A, et al. (June 1998). "The National Diet and Nutrition Survey: people aged 65 years and over". Nutrition & Food Science. 98 (3): 133–134. doi:10.1108/00346659810209791.
161. Bates B, Prentice A, Bates C, Swan G (2011). National Diet and Nutrition Survey: Headline Results from Years 1, 2 and 3 (combined) of the Rolling Programme 2008/09 – 2010/11 (Report).
162. Thamm M, Mensink GB, Thierfelder W (December 1999). "[Folic acid intake of women in childbearing age]". Gesundheitswesen (in German). 61 Spec No: S207–S212. PMID   10726422.
163. McLean E, de Benoist B, Allen LH (June 2008). "Review of the magnitude of folate and vitamin B12 deficiencies worldwide". Food and Nutrition Bulletin. 29 (2 Suppl): S38–S51. doi:10.1177/15648265080292S107. PMID   18709880. S2CID   5562175.
164. García-Casal MN, Osorio C, Landaeta M, Leets I, Matus P, Fazzino F, et al. (September 2005). "High prevalence of folic acid and vitamin B12 deficiencies in infants, children, adolescents and pregnant women in Venezuela". European Journal of Clinical Nutrition. 59 (9): 1064–1070. doi:10.1038/sj.ejcn.1602212. PMID   16015269. S2CID   2453114.
165. Cuevas-Nasu L, Mundo-Rosas V, Shamah-Levy T, Méndez-Gómez Humaran I, Avila-Arcos MA, Rebollar-Campos M, et al. (April 2012). "Prevalence of folate and vitamin B12 deficiency in Mexican children aged 1 to 6 years in a population-based survey". Salud Publica de Mexico. 54 (2): 116–124. doi: 10.1590/S0036-36342012000200007 . PMID   22535170.
166. Laillou A, Pham TV, Tran NT, Le HT, Wieringa F, Rohner F, et al. (April 17, 2012). Smith B (ed.). "Micronutrient deficits are still public health issues among women and young children in Vietnam". PLOS ONE. 7 (4): e34906. Bibcode:2012PLoSO...734906L. doi: 10.1371/journal.pone.0034906 . PMC   3328495 . PMID   22529954.
167. Green TJ, Venn BJ, Skeaff CM, Williams SM (February 2005). "Serum vitamin B12 concentrations and atrophic gastritis in older New Zealanders". European Journal of Clinical Nutrition. 59 (2): 205–210. doi:10.1038/sj.ejcn.1602059. PMID   15483636. S2CID   31599027.
168. Taneja S, Bhandari N, Strand TA, Sommerfelt H, Refsum H, Ueland PM, et al. (November 2007). "Cobalamin and folate status in infants and young children in a low-to-middle income community in India". The American Journal of Clinical Nutrition. 86 (5): 1302–1309. doi: 10.1093/ajcn/86.5.1302 . PMID   17991639.
169. Refsum H, Yajnik CS, Gadkari M, Schneede J, Vollset SE, Orning L, et al. (August 2001). "Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians". The American Journal of Clinical Nutrition. 74 (2): 233–241. doi: 10.1093/ajcn/74.2.233 . PMID   11470726.
170. Siekmann JH, Allen LH, Bwibo NO, Demment MW, Murphy SP, Neumann CG (November 2003). "Kenyan school children have multiple micronutrient deficiencies, but increased plasma vitamin B-12 is the only detectable micronutrient response to meat or milk supplementation". The Journal of Nutrition. 133 (11 Suppl 2): 3972S–3980S. doi: 10.1093/jn/133.11.3972S . PMID   14672298.
171. Smith AD, Warren MJ, Refsum H (2018). "Chapter Six – Vitamin B₁₂". In Eskin NA (ed.). Advances in Food and Nutrition Research. Vol. 83. Academic Press. pp. 215–279. doi:10.1016/bs.afnr.2017.11.005. ISBN   978-0-12-811803-0. PMID   29477223.
172. Greer JP (2014). Wintrobe's Clinical Hematology Thirteenth Edition. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins. ISBN   978-1-4511-7268-3. Chapter 36: Megaloblastic anemias: disorders of impaired DNA synthesis by Ralph Carmel
173. "George H. Whipple – Biographical". www.nobelprize.org. Retrieved October 10, 2017.
174. The Nobel Prize in Physiology or Medicine 1934, Nobelprize.org, Nobel Media AB 2014. Retrieved December 2, 2015.
175. McDowell LR (2008). Vitamins in Animal and Human Nutrition (2nd ed.). Hoboken: John Wiley & Sons. p. 525. ISBN   978-0-470-37668-3. Archived from the original on September 8, 2017.
176. "Soils". Waikato University. Archived from the original on January 25, 2012. Retrieved January 16, 2012.
177. "Hedley Ralph Marston 1900–1965". Biographical Memoirs of Deceased Fellows. Australian Academy of Science. Archived from the original on December 6, 2006. Retrieved May 12, 2013.

Further reading

• Greer JP (2014). Wintrobe's Clinical Hematology Thirteenth Edition. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins. ISBN   978-1-4511-7268-3. Chapter 36: Megaloblastic anemias: disorders of impaired DNA synthesis by Ralph Carmel. The gold standard of clinical hematology textbooks since 1942.
• Hunt A, Harrington D, Robinson S (September 2014). "Vitamin B12 deficiency". BMJ. 349: g5226. doi:10.1136/bmj.g5226. PMID   25189324. S2CID   28782021.
• Pacholok SM, Stuart JJ (2011). Could It Be B₁₂?: An Epidemic of Misdiagnoses. Fresno, CA: Linden Publishing. ISBN   978-1-61035-065-5.
• Hooper M (2012). Pernicious Anaemia: The Forgotten Disease – the causes and consequences of Vitamin B₁₂ Deficiency. London: Hammersmith Press. ISBN   978-1-78161-004-6.